Articles tagged with Esophageal Cancer
A large-scale genome-wide association study identified four genetic variants associated with an increased risk of esophageal cancer and its precursor, Barrett's esophagus. The study pooled data from over 8,000 participants and found that the genetic variants were more strongly linked to early stages of disease development.
A study by Rhode Island Hospital researchers found a pathway connecting acid reflux and esophageal cancer, suggesting that blocking this pathway with proton pump inhibitors could prevent esophageal cancer. Patients with persistent acid reflux complicated by Barrett's esophagus may be at higher risk of developing esophageal cancer.
The American Gastroenterological Association has partnered with the Gastric Cancer Foundation to create a new grant supporting research in gastric and esophageal cancer. The AGA Institute will match the GCF's $1.125M commitment, resulting in a $2.25M endowment for young investigators.
A new study by researchers at the University of Pennsylvania School of Medicine found that minimally invasive therapies can effectively remove damaged cells from patients with Barrett's esophagus, reducing cancer progression. In over two-thirds of cases, patients had no signs of disease return for years.
Researchers evaluated CT scans of patients with localized esophageal cancer before and after chemotherapy to identify changes in tumor texture. Smaller change in skewness following chemotherapy was a significant prognostic factor, with median overall survival increasing from 11.1 months to 36.1 months.
The Case Western Reserve University School of Medicine has received a grant to study gastric cancers and explore the role of interleukin-33 (IL-33) in inflammation and its potential link to gastrointestinal cancers. The research aims to identify more effective treatments for these deadly diseases, which are currently incurable.
Children born prematurely are at increased risk of developing esophageal adenocarcinoma due to gastroesophageal reflux disease (GERD) and chronic exposure to acid reflux. The study found that being small for gestational age or having a short duration of gestation also increases the risk of esophagitis.
A meta-analysis of 11 studies involving almost 1 million patients found that statin use was associated with a significant 30% reduction in esophageal cancer incidence. The study also found a 41% decrease in the risk of adenocarcinoma of the esophagus among patients with Barrett's esophagus.
Phase III data show gefitinib improves quality-of-life measures and extends progression-free survival in esophageal cancer. The COG study included 450 patients who had progressed after first line chemotherapy and received either placebo or the EGFR-inhibitor gefitinib.
A meta-analysis of 17 studies found that quitting alcohol significantly lowers the risk of esophageal cancer, with about half of this reduction occurring within 4-5 years. The study also suggests that moderate alcohol consumption may have beneficial health effects on cardiovascular disease and other conditions.
The ASGE initiative focuses on developing guidelines for real-time imaging of Barrett's esophagus, addressing the need for more accurate surveillance protocols. High-risk individuals require regular endoscopy screenings, but current methods have shortcomings due to dysplasia and cancer sampling errors.
A new study published in Clinical Gastroenterology and Hepatology suggests that aspirin use may protect against Barrett's esophagus (BE), the largest known risk factor for esophageal cancer. High-dose aspirin was significantly associated with decreased BE risk, but caution is advised due to potential cardiovascular benefits.
Research shows that PET/CT imaging can change management plans for 34% of esophageal cancer patients, leading to improved survival rates. The technique provides powerful prognostic stratification and should be incorporated into routine clinical practice.
A recent study published in Clinical Gastroenterology and Hepatology suggests that GERD-related inflammation may contribute to the development of esophageal cancer. Researchers analyzed data from over 33,000 patients with GERD and found a significant increase in esophageal cancer incidence among those with erosive reflux disease.
A new study from Karolinska Institutet found that patients who suffered serious post-operative complications after esophageal cancer surgery had more symptoms of breathlessness, fatigue and eating problems, with impairments lasting for five years. Patients require long-term monitoring to identify and target any problems quickly.
Researchers at Moffitt Cancer Center found no link between body mass index (BMI) and post-surgical complications or survival rates among esophageal cancer patients. The study, published in the Journal of Gastrointestinal Surgery, included 303 patients treated with chemotherapy, radiation, and surgery.
Researchers identify non-canonical activation of Gli1 protein through the mTOR pathway, promoting esophageal cancer development. A combination of RAD-001 and GDC-0449 inhibits tumor growth by targeting both pathways.
A new study published in Gastroenterology reveals that Barrett's esophagus patients who smoke are twice as likely to develop esophageal cancer. Tobacco smoking emerged as the strongest lifestyle risk factor for cancer progression in this patient group.
Researchers at Columbia University Irving Medical Center identified the origin of esophageal adenocarcinoma as the gastric cardia, where bile acid and inflammatory cytokines activate stem cells. The study highlights possible targets for new clinical therapies, including inhibiting notch signaling.
Researchers have made significant progress in detecting and treating gastrointestinal cancers with new biomarkers, test, and treatments. Studies show promising results for detecting early stage pancreatic cancer and improving survival in patients with metastatic colorectal cancer.
Scientists have discovered a new mechanism to identify Barrett's dysplasia cells using fluorescent probes and sugar molecules. This technology has the potential to monitor patients with pre-cancerous conditions and prevent the development of esophageal cancer.
A study of 778 patients found that obesity significantly increases the risk of cancer recurrence and death after esophageal cancer surgery. Patients with a body mass index of 30 or higher had only an 18% five-year survival rate, compared to 36% for those of normal weight.
A multidisciplinary research program aims to study the origins and pathogenesis of Barrett's esophagus, focusing on chronic inflammation and bile acids. The team will develop preventive and therapeutic treatments targeting stem/progenitor cells.
The Mayo Clinic Facebook group provides a platform for patients to share their experiences and challenges with esophageal cancer. The group, led by Dr. Herbert Wolfsen, has become an invaluable resource for patients, caregivers, and medical professionals.
Research highlights social media's benefits and risks in delivering healthcare information to patients, particularly those with esophageal cancer and IBD. The Mayo Clinic's Facebook group for esophageal cancer survivors provides a supportive community, while YouTube content is often misleading and should be approached with caution.
The university will support the development of an understanding of Barrett's esophagus and its conversion to esophageal carcinoma through genetic and environmental research. Researchers aim to reduce mortality associated with this deadly cancer, which has seen a six-fold increase in recent years.
A University of North Carolina at Chapel Hill researcher is leading a collaborative network to study the genetic determinants of Barrett's esophagus and esophageal adenocarcinoma. The network aims to develop new methods for identifying individuals at risk, early detection, and monitoring Barrett's esophagus progression.
A new study from the University of Pittsburgh found that medically treated GERD patients with mild or no symptoms are at a higher risk for developing esophageal cancer. The research suggests that even asymptomatic patients may benefit from Barrett's esophagus screening to prevent cancerous transformation.
Researchers discovered that Barrett's esophagus arises from embryonic cells present in all adults, which can rapidly grow and form unusual tissue when the esophagus is damaged by acid reflux. This finding provides a potential target for preventing esophageal cancers.
Researchers discovered that Barrett's esophagus, a precursor to esophageal cancer, arises from a small group of leftover embryonic cells present in all adults. This finding opens up new avenues for therapeutic intervention to prevent the progression of cancer. The study used mouse models and identified specific cell surface markers to ...
Research reveals that leftover embryonic cells found in all adults may be precursors of deadly esophageal cancers, including Barrett's esophagus. The study suggests targeting these precursor cells as a potential strategy for stopping the disease before it starts.
A large study published in the Journal of the National Cancer Institute found that patients with Barrett's esophagus have a lower risk of esophageal cancer than previously thought. Men and individuals aged 60-69 were found to be at higher risk, highlighting the importance of personalized risk scores.
A University of Michigan Health System study shows surgery mortality dropped substantially for eight different high-risk surgeries performed on 3.2 million Medicare patients from 1999 to 2008. High-volume hospitals and their expertise drove a significant decline in deaths, particularly in pancreatectomy and cystectomy.
Researchers at University of Rochester Medical Center have identified two genes, CDK6 and CDK4, that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment. The study found that targeting these genes may halt the growth of cancer cells.
Researchers discovered that a tumor suppressor gene, p120, can actually contribute to cancer development when it's absent. In mice models, the loss of p120 led to hyperactivated immune systems and pro-tumor generating cells that promoted cancer growth.
A new international study suggests that consuming strawberries may help protect against esophageal cancer by slowing precancerous growth. Six months of daily strawberry consumption decreased histological grade and reduced cancer-related molecular events in patients with esophageal precancerous lesions.
Researchers found that eating six months of freeze-dried strawberries decreased histological grade of precancerous lesions and reduced cancer-related molecular events. The study suggests that strawberries may be a safe and effective chemopreventive agent for esophageal cancer prevention.
A research article reports a case of iatrogenic sigmoid perforation successfully repaired using a combination of three endoscopic techniques. The patient underwent laparoscopic surgery four days later due to another polyp, but the sigmoid repair was found to be complete.
Research from the BEACON Consortium found no association between heavy drinking and esophageal adenocarcinoma, contrasting with a well-established link to squamous cell carcinoma. Light drinkers had lower risk of these cancers than non-drinkers.
For patients with confirmed high-grade dysplasia, endoscopic eradication therapy is recommended. Surveillance may be considered in some cases, but it is not a substitute for treatment. The American Gastroenterological Association recommends regular screening for cardiovascular risk factors and interventions.
Researchers developed a device using angle-resolved low coherence interferometry to detect pre-cancerous cells in the esophagus lining. The technology holds promise for earlier detection and targeted biopsies, potentially improving treatment outcomes for esophageal cancer.
Researchers are exploring the potential link between vitamin D intake and a protein that may help prevent Barrett's esophagus from turning into cancer. Patients with Barrett's esophagus will take vitamin D weekly for four months to measure its effects on esophageal cancer risk.
A study of over 80,000 patients in the UK found no significant association between oral bisphosphonate use and an increased risk of esophageal or gastric cancer. The analysis excluded patients with less than 6 months follow-up, resulting in 41,826 members in each group.
Children who are extremely obese have a 40 percent higher risk of gastroesophageal reflux disease (GERD), while those who are moderately obese have a 30 percent higher risk. Researchers used electronic health records to conduct the study, which established an association between obesity and GERD in children.
A recent study found that gastric cancer incidence has declined globally over the past 30 years for all age groups and races, except for young white adults. The majority of noncardia gastric cancers are attributed to chronic Helicobacter pylori infection.
Research findings indicate that extracapsular lymph node involvement is a negative prognostic factor for esophageal cancer, leading to significantly worse long-term survival rates. The study suggests that this involvement should be taken into account for a revised staging system.
A research team investigated S1P receptor expression profiles in human esophageal cancer cells, finding that S1P5 inhibits cell proliferation and migration. This study suggests that S1P5 or its associated signaling molecules may serve as a future biotherapy strategy for esophageal cancer.
A new endoscopic scanning technique called EPSS has been developed to detect dysplasia in Barrett's esophagus, a precursor to esophageal cancer. The technique uses polarized light scattering spectroscopy to identify cellular changes on a subcellular scale, enabling early detection and potentially improving treatment outcomes.
Researchers developed a new endoscopic technique, the over-the-scope-clip (OTSC), to close chronic gastrointestinal perforations. The study successfully closed two gastro-cutaneous fistulas and suggests OTSC as a least invasive method for closing small fistulas or leaks.
A study comparing preoperative and postoperative chemoradiotherapy to surgery alone in patients with resectable esophageal squamous cell carcinoma found significant differences in overall survival and progression-free survival. Perioperative chemoradiotherapy maximizes long-term survival, but increases toxicity.
A new study by Northwestern University's Feinberg School of Medicine and the American College of Surgeons found that community hospitals can offer safe surgical options for certain types of cancer surgeries. Younger patients with few pre-existing illnesses have similar survival rates at both community hospitals and specialized cancer c...
A study published in the World Journal of Gastroenterology found that PEG placement does not guarantee elimination of gastroesophageal reflux. The researchers identified factors contributing to GER persistence, including reflux esophagitis and altered gastroesophageal flap valve function.
A large-scale genome-wide association study will be conducted to investigate the interplay between genetic and environmental factors in Barrett's esophagus and esophageal adenocarcinoma. The study aims to identify biological pathways contributing to this rapidly fatal cancer.
Researchers found that Barrett's esophagus patients have comparable survival rates to the general population, with a 10-year overall survival rate of 68%. Esophageal cancer was not significantly more common among these patients.
Researchers at Mayo Clinic have found that early stage cancers of the esophagus can be treated effectively with less-invasive, organ-sparing endoscopic therapy. This approach was compared to traditional surgical removal of the esophagus and showed comparable overall mortality rates.
A study investigated QOL of 149 patients with upper third gastric cancer treated with proximal gastrectomy and additional reconstruction. The EA procedure showed the best postoperative QOL, improving recovery of body weight and reducing symptoms like heartburn and belching.
A surgical procedure, palliative cardia resection with gastroesophageal reconstruction, was performed on a 82-year-old man with iatrogenic perforation of adenocarcinoma of the GE junction. The patient recovered quickly and showed no complaints after treatment.
A new study finds that radiofrequency ablation can completely reverse Barrett's esophagus and reduce the risk of esophageal cancer. The procedure, which involves targeted thermal energy, showed significant success in treating patients with dysplastic Barrett's esophagus.
A landmark UNC-led study finds radiofrequency ablation significantly effective in treating dysplasia in people with Barrett's esophagus, eradicating abnormal cells and reducing cancer risk. The procedure showed high rates of complete eradication of intestinal metaplasia and progression to disease.
A new radiofrequency ablation procedure has shown promise in eliminating signs of Barrett's esophagus and reducing the risk of cancer progression. In a multicenter trial, patients treated with the procedure experienced significant reductions in dysplasia and abnormal cells.